Keyphrases
Bilateral Synchronous
7%
Cancer-specific Survival
21%
Cytoreductive Nephrectomy
7%
Cytoreductive Surgery
7%
Early Complications
7%
Late Complications
7%
Mayo Clinic
7%
Metastatic Renal Cell Carcinoma (mRCC)
7%
Nephrectomy
7%
Nephron-sparing Surgery
100%
No Significant Difference
7%
Perioperative Complication Rate
7%
Radical Nephrectomy
35%
Renal Cell Carcinoma
100%
Renal Function
7%
Solitary Kidney
21%
Survival Rate
21%
Synchronous Diseases
7%
Time to Progression
7%
Medicine and Dentistry
Cancer Specific Survival
21%
Clear Cell Renal Cell Carcinoma
100%
Diseases
7%
Kidney Function
7%
Kidney Metastasis
7%
Nephrectomy
14%
Nephron Sparing Surgery
100%
Postoperative Complication
7%
Radical Nephrectomy
35%
Solitary Kidney
21%
Survival Rate
21%